Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 70 results found. Search for [ U.S. Food and Drug Administration ]

Results 1 to 21 of 70
BusinessToday.In
June 22, 2020
Stock Market LIVE Updates on June 19: Reliance Industries, Bajaj Finserv, Bajaj Finance, Bajaj Auto, IndusInd Bank and ICICI Bank were among the top gaines on Sensex pack. On the contrary, TCS, ONGC, M&M and Infosys were among the top laggards


Reuters
June 18, 2020
Data from a UK-led clinical trial known as the Recovery trial found last week that the anti-malaria drug showed no benefit for patients with COVID-19


Reuters
June 4, 2020
In the first major study comparing hydroxychloroquine to a placebo to gauge its effect against the new coronavirus, University of Minnesota researchers tested 821 people who had recently been exposed to the virus or lived in a high-risk household


BusinessToday.In
June 3, 2020
Stock Market LIVE Updates: Companies set to announce their earnings are Aurobindo Pharma, DCM Shriram, BPCL, Cholamandalam Investment, MAS Financial Services, Duncan Engineering, DISA, Shriram Asset Management among others


Reuters
June 2, 2020
Remdesivir is the first drug to show improvement in COVID-19 patients in formal clinical trials


BusinessToday.In
May 24, 2020
Coronavirus vaccine update: Experts have welcomed the findings, saying the results showed patients on remdesivir cut their recovery time by 27 per cent


Reuters
May 22, 2020
The FDA approved emergency use of remdesivir on May 1 based on preliminary results from a National Institute of Allergy and Infectious Diseases (NIAID) trial showing that the drug cut hospital stays by 31%, or about four days, compared with a placebo


Reuters
May 20, 2020
J&J in December said its testing found no asbestos in its Baby Powder after tests conducted by the U.S. Food and Drug Administration discovered trace amount


Associated Press
May 19, 2020
The Food and Drug Administration warned health professionals last month that the drug should not be used to treat COVID-19 outside of hospital or research settings, due to sometimes fatal side effects


Chitranjan Kumar
New Delhi, May 18, 2020
Shares of Moderna soared 39 per cent in premarket trading after the biotech announced positive interim data from a phase 1 clinical study of its experimental COVID-19 vaccine


Reuters
May 16, 2020
Interest in Gilead's drug has been high given some promising early data and the lack of approved treatments or preventive vaccines for COVID-19, the disease caused by the novel coronavirus


Reuters
May 16, 2020
World's No.2 cigarette company said once it gets approval from the U.S. Food and Drug administration (FDA) for the vaccine, it would progress to Phase 1 trials or testing on humans


Reuters
May 8, 2020
With no other approved treatments for COVID-19, interest in the drug is growing around the world. Administered by intravenous infusion, it was granted authorisation last week by the U.S


Reuters
May 6, 2020
Gilead last week received the U.S. Food and Drug Administration's emergency use authorization for using remdesivir as a treatment against COVID-19, after the drugmaker provided data showing the drug had helped coronavirus patients


BusinessToday.In
New Delhi, May 4, 2020
Panel in offing to grant clearances to businesses within 3 months: Nitin GadkariUnion MSME Minister Nitin Gadkari on Sunday said that the central government will set up a panel to provide necessary clearances needed by businesses within three months in a bid to attract foreign investment in micro, small and medium enterprises (MSMEs). He said that a Joint Secretary-level officer has already been appointed to look after foreign investments in the MSME sector.Roche wins U.S. nod for...


Reuters
May 1, 2020
Coronavirus update: As the U.S. coronavirus death toll topped 60,000 on Wednesday - the highest in the world - doctors in the United States are desperate for anything that might alter the course of the disease, which attacks the lungs and can shut down other organs in severe cases


Reuters
April 30, 2020
U.S. Food and Drug Administration said it has been in discussions with Gilead about making remdesivir available to patients as quickly as possible, but the agency declined to comment on any plans to grant the drug regulatory approval


BusinessToday.In
April 27, 2020
Sensex, Nifty Live News Today: Kotak Bank, Axis Bank, Bajaj Finance, IndusInd Bank, HDFC, ICICI Bank and Reliance Industries were among the top gainer in the Sensex pack. Cipla, JSW Steel, IndusInd Bank, Reliance Industries, Maruti were trading as top performers on Nifty. Power Grid and NTPC were the only losers on both Sensex and Nifty today.


BusinessToday.In
April 27, 2020
Stocks to watch today on April 27: Mindtree, JK Paper, ICICI Prudential, Future Lifestyle, Tata Steel, Bank of Baroda among others are the top stocks to watch out for in Monday's trading session. Adani Power, Sasken, HDFC Life, Ambuja Cement, IndusInd Bank are the companies that will be reporting their March quarterly results today.


Reuters
April 20, 2020
Hydroxycloroquine (HCQ) has received U.S. Food and Drug Administration (FDA) emergency use authorization for coronavirus disease, but so far there is no scientific proof it helps those afflicted


PAGES 1 OF 4  1234